logo
ResearchBunny Logo
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs

Medicine and Health

Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs

R. Capuano, L. Prosperini, et al.

This study investigated the impact of a third mRNA vaccine dose on COVID-19 outcomes in multiple sclerosis patients treated with ocrelizumab, fingolimod, and natalizumab. The research, conducted by Rocco Capuano and colleagues, found that while some differences in COVID-19 symptoms and hospitalization rates existed among treatments, no deaths occurred, and the booster dose showed effectiveness against severe COVID-19.

00:00
00:00
Playback language: English
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
0

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny